| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/03/2004 | US20040106545 Compounds and methods for modulating cell adhesion |
| 06/03/2004 | US20040106544 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements |
| 06/03/2004 | US20040106541 Protein complex from ion-exchange chromatography for treatment of bacterial infections |
| 06/03/2004 | US20040106194 Genetically engineered gene transfer vector comprising mutiple viral serotype sequences and E4 region of preferential virus for use as transfer tool in gene therapy and vaccine preparation |
| 06/03/2004 | US20040106193 Novel adenoviral vector and methods for making and using the same |
| 06/03/2004 | US20040106179 Comprises lyases enzymatic peptide for use in screening modulator for treatment and prevention of cardiovascular disorders |
| 06/03/2004 | US20040106174 Designing immunogens |
| 06/03/2004 | US20040106173 Comprises polypeptide associated with cell proliferation, viability and morphogenesis for use in identifying and screening fungicides; veterinary medicine |
| 06/03/2004 | US20040106171 Peptides with anti-hypertensive properties |
| 06/03/2004 | US20040106161 Using monoclonal antibody to prevent interaction between tyrosine kinase receptor and ligand; designing treatment for tumors; immunotherapy; antitumor agents |
| 06/03/2004 | US20040106149 Novel gpcr hfrbn63 |
| 06/03/2004 | US20040106148 Polypeptides |
| 06/03/2004 | US20040106134 Comprises genetically engineered immunoglobulin for use in the treatment of bone disorders |
| 06/03/2004 | US20040106133 Method for detecting ammonia-oxidizing bacteria |
| 06/03/2004 | US20040106132 Oligonucleotide for generating gene expression profiles in presence of enzyme inhibitors; cancer diagnosis and treatment; antisense therapy |
| 06/03/2004 | US20040106127 Comprises nucleotide sequences coding human adult and embryonic whole brain polypeptides; microarry for genome analysis; proteomics |
| 06/03/2004 | US20040106123 Regulation of human g protein-coupled receptor |
| 06/03/2004 | US20040106119 Crystal structure of the mouse apoptosis-inducing factor AIF and applications of such structural data to structure-based identification, screening, or design of AIF agonists or antagonists as well as AIF fragments, mutants or variants |
| 06/03/2004 | US20040106118 Preparing transgenic vectors capable of transformation, propagation and expression of cell surface ligand binding activity in host cells; drug screening |
| 06/03/2004 | US20040106116 Methods and materials relating to hematopoietic cytokine-like polypeptides and polynucleotides |
| 06/03/2004 | US20040106115 Sodium channel (rnav1.5a) and use thereof |
| 06/03/2004 | US20040106105 Vaccine |
| 06/03/2004 | US20040106100 Dna vaccines encoding hiv accessory proteins |
| 06/03/2004 | US20040105901 foliage and stems of plant species from the family Rosaceae, genus Prunus, yield natural pesticides when macerated followed by hydrodistillation of the biomass yielding a concentrated solution of organic volatile compounds that act synergistically |
| 06/03/2004 | US20040105871 Pox viral vector plasmid construct comprising a vaccine insert that encodes at least two antigens; DNA-based vaccine can be tailored for the type of immune response that will be mobilized |
| 06/03/2004 | US20040105868 HCV epitopes vaccines for immunization for Hepatitis C polypeptides for CD antigens |
| 06/03/2004 | US20040105860 Modulation of endothelial cells and cell proliferation and endothelial cells |
| 06/03/2004 | US20040105846 Polynucleotides encoding G protein-coupled receptors |
| 06/03/2004 | US20040105841 Interferons, uses and compositions related thereto |
| 06/03/2004 | US20040105840 Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
| 06/03/2004 | DE10361201A1 New biologically active oligopeptides with modified termini, useful as insecticides, acaricides, antibacterials and antitumor agents, especially neoefrapeptins from Geotrichum candidum |
| 06/03/2004 | DE10254652A1 Knock-in mouse, useful in screening agents for treatment of epilepsy, contains a missense mutation in the beta2-subunit of the neuronal acetylcholine receptor |
| 06/03/2004 | DE10254601A1 Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung Differentially expressed in tumors gene products and their use |
| 06/03/2004 | CA2847795A1 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 06/03/2004 | CA2599222A1 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 06/03/2004 | CA2544467A1 Paralytic peptide for use in neuromuscular therapy |
| 06/03/2004 | CA2514089A1 Activation of peptide prodrugs by hk2 |
| 06/03/2004 | CA2507373A1 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 06/03/2004 | CA2506737A1 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 06/03/2004 | CA2506695A1 Genetic constructs and compositions comprising rre and cte and uses thereof |
| 06/03/2004 | CA2506684A1 Immunogenic epitopes for fibroblast growth factor 5 (fgf-5) presented by hla-a3 and hla-a2 |
| 06/03/2004 | CA2506625A1 Autocrine growth factor receptor antibodies and methods |
| 06/03/2004 | CA2506594A1 A method for the crystallization of human serum albumin |
| 06/03/2004 | CA2506331A1 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 06/03/2004 | CA2506328A1 Use of hmgb fragments as anti-inflammatory agents |
| 06/03/2004 | CA2506317A1 Method for continuous, automated blending of solutions from acids and bases |
| 06/03/2004 | CA2506246A1 Products and processes for modulating peptide-peptide binding domain interactions |
| 06/03/2004 | CA2506243A1 Amplified genes involved in cancer |
| 06/03/2004 | CA2506129A1 2'-branched nucleosides and flaviviridae mutation |
| 06/03/2004 | CA2505919A1 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 06/03/2004 | CA2505682A1 Use of hmgb polypeptides for increasing immune responses |
| 06/03/2004 | CA2505601A1 Complement receptor 2 targeted complement modulators |
| 06/03/2004 | CA2505479A1 Molecular interactions in neurons |
| 06/03/2004 | CA2505385A1 Process for the purification of tnf-binding proteins using imac |
| 06/03/2004 | CA2505167A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | CA2505085A1 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway |
| 06/03/2004 | CA2504930A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 06/03/2004 | CA2504715A1 Vaccine |
| 06/03/2004 | CA2504654A1 Vaccine against hcv |
| 06/03/2004 | CA2504331A1 Bacteriophage having modified holin and uses thereof |
| 06/03/2004 | CA2504267A1 Interferon-alpha polypeptides and conjugates |
| 06/03/2004 | CA2502668A1 Fully human antibody fab fragments with human interferon-gamma neutralizing activity |
| 06/03/2004 | CA2483870A1 Interacting site for gp41 on gp120 of hiv-1 |
| 06/02/2004 | EP1424394A2 TAT transdominant variants from HIV virus |
| 06/02/2004 | EP1424393A2 Mammalian cytokine-like polypeptide-10 |
| 06/02/2004 | EP1424392A1 Novel secretory proteins and dna thereof |
| 06/02/2004 | EP1424391A1 Gene panel participating in liver astrocyte activation |
| 06/02/2004 | EP1424390A1 The intact hepatitis c virus and the method for culturing it in a vitro cell culture |
| 06/02/2004 | EP1424387A1 Method of extended culture for antigen-specific cytotoxic t lymphocytes |
| 06/02/2004 | EP1424344A1 Modified cDNA factor VIII and its derivates |
| 06/02/2004 | EP1424343A1 Peptide Conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 06/02/2004 | EP1424342A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide |
| 06/02/2004 | EP1423708A1 Compositions and methods for aa4rp assay |
| 06/02/2004 | EP1423707A1 Methods of screening molecules that are used to prevent cardiovascular diseases |
| 06/02/2004 | EP1423704A1 Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders |
| 06/02/2004 | EP1423701A2 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423695A2 Androgen receptor knock-out transgenic animals |
| 06/02/2004 | EP1423538A2 Methods of using 5433, a human calcium channel family member |
| 06/02/2004 | EP1423530A2 G-protein coupled receptor arrays |
| 06/02/2004 | EP1423522A2 Hepatitis c virus replicons and replicon enhanced cells |
| 06/02/2004 | EP1423521A2 Flax (linum usitatissimim l.) seed-specific promoters |
| 06/02/2004 | EP1423519A2 G-protein coupled receptor and dna sequences thereof |
| 06/02/2004 | EP1423515A1 Anti-aging and wound healing compounds |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423427A2 Nogo receptor homologues and their use |
| 06/02/2004 | EP1423426A1 Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion |
| 06/02/2004 | EP1423425A2 Receptor, the use thereof, and mouse antibodies |
| 06/02/2004 | EP1423424A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 06/02/2004 | EP1423423A2 Methods for construction and screening of libraries of chemokine variants |
| 06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
| 06/02/2004 | EP1423421A2 Isolation and purification of p. falciparum merozoite protein-1 42 vaccine |
| 06/02/2004 | EP1423420A2 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation |
| 06/02/2004 | EP1423419A2 Hybrid and tandem expression of neisserial proteins |
| 06/02/2004 | EP1423418A1 Mutated env gene, mutated env glycoprotein and the use thereof |
| 06/02/2004 | EP1423417A2 Peptides mimicking a cryptic epitope of gp41 of hiv-1 and antibodies directed against them |
| 06/02/2004 | EP1423416A2 Allelic variants of herv-k18 provirus and their use in analysis |
| 06/02/2004 | EP1423415A2 Intracellular signaling molecules |
| 06/02/2004 | EP1423413A1 Peptidic compounds selectively binding to p-selectin |
| 06/02/2004 | EP1423409A2 Gastrokines and derived peptides including inhibitors |